Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients : The ReCap Study. / Lund, Cecilia Margareta; Mikkelsen, M. K.; Theile, S.; Michelsen, H. M.; Schultz, M.; Sengelov, L.; Nielsen, D. L.
In: Oncologist, Vol. 27, No. 2, 2022, p. E185-E193.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients
T2 - The ReCap Study
AU - Lund, Cecilia Margareta
AU - Mikkelsen, M. K.
AU - Theile, S.
AU - Michelsen, H. M.
AU - Schultz, M.
AU - Sengelov, L.
AU - Nielsen, D. L.
PY - 2022
Y1 - 2022
N2 - Background To prevent severe toxicity and hospital admissions, adequate management and recall of information about side effects are crucial and health literacy plays an important role. If age-related factors impact recall of given information and handling of side effects, revised ways to give information are required. Patients and Methods We undertook a questionnaire-based survey among 188 newly diagnosed patients with pancreatic cancer or colorectal cancer and chemo-naive patients with prostate cancer treated with adjuvant or first-line palliative chemotherapy comprising satisfaction with given information, recall of potential side effects, and handling of hypothetical side effect scenarios. We evaluated the association between baseline characteristics, ie, age, frailty (G8 score), comorbidity (Charlson Comorbidity Index), cognitive function (Mini-Cog), satisfaction, recall of information, and handling of side effects. Results Reduced ability to recall information about several side effects (eg, chest pain) was associated with older age (odds ratio adjusted for cancer [aOR] 0.94 [95% CI, 0.88-0.98]) and poor cognitive screening (aOR 0.56 [95% CI, 0.33-0.91]). Insufficient or dangerous handling of side effects was associated with older age (aOR 0.96 (95% CI, 0.92-0.99)) and cognitive impairment (aOR 0.70 [95% CI, 0.50-0.95]). Conclusion Older age and poor cognitive screening may impact patients' ability to understand and adequately handle chemotherapy-related side effects. Cognitive screening and focus on individual ways to give information including assessment of recall and handling are needed.
AB - Background To prevent severe toxicity and hospital admissions, adequate management and recall of information about side effects are crucial and health literacy plays an important role. If age-related factors impact recall of given information and handling of side effects, revised ways to give information are required. Patients and Methods We undertook a questionnaire-based survey among 188 newly diagnosed patients with pancreatic cancer or colorectal cancer and chemo-naive patients with prostate cancer treated with adjuvant or first-line palliative chemotherapy comprising satisfaction with given information, recall of potential side effects, and handling of hypothetical side effect scenarios. We evaluated the association between baseline characteristics, ie, age, frailty (G8 score), comorbidity (Charlson Comorbidity Index), cognitive function (Mini-Cog), satisfaction, recall of information, and handling of side effects. Results Reduced ability to recall information about several side effects (eg, chest pain) was associated with older age (odds ratio adjusted for cancer [aOR] 0.94 [95% CI, 0.88-0.98]) and poor cognitive screening (aOR 0.56 [95% CI, 0.33-0.91]). Insufficient or dangerous handling of side effects was associated with older age (aOR 0.96 (95% CI, 0.92-0.99)) and cognitive impairment (aOR 0.70 [95% CI, 0.50-0.95]). Conclusion Older age and poor cognitive screening may impact patients' ability to understand and adequately handle chemotherapy-related side effects. Cognitive screening and focus on individual ways to give information including assessment of recall and handling are needed.
KW - age
KW - chemotherapy
KW - side effects
KW - information
KW - recall
KW - OLDER-ADULTS
KW - GERIATRIC ASSESSMENT
KW - COGNITIVE IMPAIRMENT
KW - TOXICITY
KW - COMMUNICATION
KW - SURVIVORSHIP
KW - STATISTICS
KW - EXPERIENCE
KW - SURVIVAL
KW - TOOLS
U2 - 10.1093/oncolo/oyab034
DO - 10.1093/oncolo/oyab034
M3 - Journal article
C2 - 35641212
VL - 27
SP - E185-E193
JO - Oncologist
JF - Oncologist
SN - 1083-7159
IS - 2
ER -
ID: 308118682